drugset
drugset / Trial / NCT01891136

Oral Peanut Immunotherapy for Peanut Allergic Patients

NCT01891136 ↗

Phase 0 Completed 36 enrolled University of North Carolina, Chapel Hill
NaSingle-groupOpen-labelTreatment

Summary

This is a study to determine if peanut oral immunotherapy (OIT) would desensitize or tolerize peanut allergic patients to peanuts in order prevent peanut allergic reactions.

Timeline

Start
2004-04
Primary completion
2014-11
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject DEFATTED POWDER OF ARACHIS HYPOGAEA L., SEMEN (PEANUTS) Protein / enzyme biologic — Oral

Indications

No indication recorded.